Camber Capital Management LP Nektar Therapeutics Transaction History

Camber Capital Management LP

$3.15 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $12.7 Million - $24.7 Million	-4,000,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $1.04 Million - $3.43 Million	250,000 Added 6.67%	4,000,000 $21.6 Million
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $3.27 Million - $4.71 Million	250,000 Added 7.14%	3,750,000 $67.4 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $24.8 Million - $30.6 Million	1,500,000 Added 75.0%	3,500,000 $60.1 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $8.28 Million - $12.7 Million	-500,000 Reduced 20.0%	2,000,000 $40 Million
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $8.3 Million - $12.4 Million	-500,000 Reduced 16.67%	2,500,000 $41.5 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $10.9 Million - $21 Million	-750,000 Reduced 20.0%	3,000,000 $53.6 Million
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $11.9 Million - $17.3 Million	750,000 Added 25.0%	3,750,000 $80.9 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $8.46 Million - $18.1 Million	500,000 Added 20.0%	3,000,000 $54.6 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $15.5 Million - $18.2 Million	500,000 Added 25.0%	2,500,000 $89 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $15.2 Million - $28.3 Million	500,000 Added 33.33%	2,000,000 $65.7 Million
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $23.2 Million - $34.2 Million	-500,000 Reduced 25.0%	1,500,000 $91.4 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $23.1 Million - $52.2 Million	500,000 Added 33.33%	2,000,000 $97.7 Million
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $106 Million - $201 Million	-1,850,000 Reduced 55.22%	1,500,000 $159 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $42.6 Million - $112 Million	-1,850,000 Reduced 35.58%	3,350,000 $200 Million
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $92.5 Million - $125 Million	5,200,000	5,200,000 $125 Million

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$15.9 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$15.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$13.1 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$9.4 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.2 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $187M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Account